The Biologics Contract Development Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Biologics Contract Development Market:
https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report
According to The Business Research Company’s Biologics Contract Development Global Market Report 2024, The biologics contract development market size has grown rapidly in recent years. It will grow from $6.94 billion in 2023 to $7.7 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to biologics market growth, rise in biopharmaceuticals, complexity of biologics, patent expirations, cost efficiency..
The biologics contract development market size is expected to see rapid growth in the next few years. It will grow to $11.68 billion in 2028 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to digitalization and data analytics, risk management, flexibility and scalability, burgeoning investment in r&d, precision medicine and personalized therapies.. Major trends in the forecast period include regenerative medicine, risk mitigation strategies, global collaborations, advanced technologies, technological integration..
The rising prevalence of chronic diseases is expected to propel the biologics contract development market going forward. Chronic diseases refer to an illness that lasts for a year or longer that requires ongoing medical attention. The rise in chronic disease cases is increasing the demand for developing novel drugs, including biologics, thereby promoting the biologics contract development market. For instance, according to data published in April 2021 by the World Health Organization, a Switzerland-based health organization for international public health, 41 million people die every year due to chronic diseases globally, close to 71% of all deaths. Therefore, the rising prevalence of chronic diseases will drive the growth of the biologics contract development market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8219&type=smp
The biologics contract development market covered in this report is segmented –
1) By Source: Microbial, Mammalian, Others Soruces
2) By Indication: Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others Indications
3) By Product Service: Cell Line Development, Process Development, Others Product Services
Technological advancements are gaining popularity in the biologics contract development market. Major companies in the biologics contract development market are integrating advanced technologies to sustain their position in the market. For instance, in January 2022, Lonza, a Switzerland-based contract manufacturing and development solutions company, launched bYlok technology platform to design and manufacture bispecific antibodies. It helps to solve the light-heavy chain mispairing issue with high yields, >95% accuracy, and the ability to maintain a mAb-like format. It can be accessed by pharma and biotech companies through a simple research license.
The biologics contract development market report table of contents includes:
- Executive Summary
- Biologics Contract Developmen Market Characteristics
- Biologics Contract Developmen Market Trends And Strategies
- Biologics Contract Developmen Market – Macro Economic Scenario
- Global Biologics Contract Developmen Market Size and Growth
.
.
.
- Global Biologics Contract Developmen Market Competitive Benchmarking
- Global Biologics Contract Developmen Market Competitive Dashboard
- Key Mergers And Acquisitions In The Biologics Contract Developmen Market
- Biologics Contract Developmen Market Future Outlook and Potential Analysis
- Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
